Literature DB >> 22125004

HIV-1: from escapism to conservatism.

Tomáš Hanke, Andrew J McMichael.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22125004     DOI： 10.1002/eji.201190072

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  11 in total

1.  T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.

Authors:  Yaowaluck Roshorm; Mathew G Cottingham; Mary-Jane Potash; David J Volsky; Tomáš Hanke
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

Review 2.  HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice.

Authors:  Timothy E Dudek; Todd M Allen
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

Review 3.  Progress in HIV-1 vaccine development.

Authors:  Barton F Haynes; M Juliana McElrath
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

4.  Structure and dynamics of full-length HIV-1 capsid protein in solution.

Authors:  Lalit Deshmukh; Charles D Schwieters; Alexander Grishaev; Rodolfo Ghirlando; James L Baber; G Marius Clore
Journal:  J Am Chem Soc       Date:  2013-10-17       Impact factor: 15.419

5.  Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens.

Authors:  Alena Reguzova; Denis Antonets; Larisa Karpenko; Alexander Ilyichev; Rinat Maksyutov; Sergei Bazhan
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.

Authors:  Beatrice Ondondo; Caroline Brennan; Alfredo Nicosia; Steven J Crome; Tomáš Hanke
Journal:  Vaccine       Date:  2013-07-02       Impact factor: 3.641

7.  A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants.

Authors:  Muhammed O Afolabi; Jorjoh Ndure; Abdoulie Drammeh; Fatoumatta Darboe; Shams-Rony Mehedi; Sarah L Rowland-Jones; Nicola Borthwick; Antony Black; Gwen Ambler; Grace C John-Stewart; Marie Reilly; Tomáš Hanke; Katie L Flanagan
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

8.  Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.

Authors:  Nicola Borthwick; Tina Ahmed; Beatrice Ondondo; Peter Hayes; Annie Rose; Umar Ebrahimsa; Emma-Jo Hayton; Antony Black; Anne Bridgeman; Maximillian Rosario; Adrian Vs Hill; Eleanor Berrie; Sarah Moyle; Nicole Frahm; Josephine Cox; Stefano Colloca; Alfredo Nicosia; Jill Gilmour; Andrew J McMichael; Lucy Dorrell; Tomáš Hanke
Journal:  Mol Ther       Date:  2013-10-31       Impact factor: 11.454

9.  The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses.

Authors:  Weidong Xu; Douglas M Watts; Margaret C Costanzo; Xiaolei Tang; Leon A Venegas; Feng Jiao; Alessandro Sette; John Sidney; Andrew K Sewell; Linda Wooldridge; Shinji Makino; John C Morrill; Clarence J Peters; June Kan-Mitchell
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

10.  Acute-phase CD8 T cell responses that select for escape variants are needed to control live attenuated simian immunodeficiency virus.

Authors:  Max Harris; Charles M Burns; Ericka A Becker; Andrew T Braasch; Emma Gostick; Randall C Johnson; Karl W Broman; David A Price; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.